VERA - Vera Therapeutics Scheduled to Present at September Investor Conferences | Benzinga
BRISBANE, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company's management team will present and participate in one-on-one meetings at four investor conferences being held next month.
Investor Conference Details:
- Citi 18th Annual BioPharma Conference
Format: Management hosting investor meetings
Date: Wednesday, September 6, 2023
- H.C. Wainwright 25th Annual Global Investment Conference
Format: Corporate Presentation and host investor meetings
Date and Time: Monday, September 11, 2023, 7:00 AM ET
Webcast: https://journey.ct.events/view
The H.C. Wainwright presentation will be available for 90 days and ...